$CBDL CBD Life Sciences, Inc. (CBDL) Engages EVIO Labs to

New Post Public Reply Private Reply Replies (0) Message Board
louied91
681
$CBDL CBD Life Sciences, Inc. (CBDL) Engages EVIO Labs to Provide Product Certification Testing of CBDL Products

https://www.otcmarkets.com/stock/CBDL/news/CB...?id=293998

SCOTTSDALE, AZ / ACCESSWIRE / March 17, 2021 / CBD Life Sciences, Inc. (OTC PINK:CBDL) ("CBD Life Science" or the "Company" , a manufacturer and distributor of organic cannabidiol based products, announces today its commitment to providing products with the highest standards for purity and potency in the CBD marketplace. In conjunction with this commitment, the Company has selected EVIO Labs ("EVIO" , for its best-in-class product CBD testing lab located in Berkeley, CA that provides ISO 17025 accredited CBD, Hemp testing services throughout the United States.

CBD Life Sciences Inc. announced that it will now provide hemp oil and hemp derived CBD product testing for product manufacturers, retailers and consumers. CBD Life Sciences Inc. will now offer EVIO LABS ISO-17025 accredited CBD Safety Panel which includes the following tests: Cannabinoid Profile, Pesticides, Heavy Metals, Microbial Impurities Mycotoxins, and Moisture Content. In addition, CBD Life Sciences Inc. customers can also test the actual products they use for Residual Solvents like butane and propane, a full list of cannabinoids, and Vitamin E Acetate a substance linked to EVALI illnesses. President & CEO Lisa Nelson states "With the recent trend of consumers purchasing more hemp oil and hemp derived CBD products, we see this ISO-17025 accredited testing solution as an opportunity to provide a needed service for our customers." Lisa Nelson also states, "Third-party testing helps hemp CBD companies ensure the quality of their products, and it provides peace of mind for consumers." "Overall, this will bring in more business from customers, retailers, & big online distributors!"

Once testing is complete, the Company will receive a Certificate of Analysis ("COA" for each sample. The COA's will be posted on the Company's revamped and upgraded website once received. EVIO Labs has full-service testing facilities that allow testing for up to 17 cannabinoids, 66 pesticides, solvents, metals, microbial impurities, 42 terpenes, water activity, moisture content, foreign material, and more. EVIO tests to the strictest standards in the country for pesticides and microbials, which gives CBD Life Sciences the confidence to know they can sell their products in every state and beyond. EVIO CEO Lori Glauser said "We are pleased CBDL, and its subsidiaries selected EVIO for its safety and compliance testing needs. EVIO has years of expertise in testing CBD products at multiple labs and is ready to test CBDLs novel products."

Greenhouse Facility Video: https://streamable.com/znupwq

CBD Life Sciences Inc. has already identified several potential cultivation sites and is aggressively pursuing amazing new opportunities in Arizona's new recreational cannabis market. This new law gives CBD Life Sciences Inc. the capability of offering licensed retailers CBD Life Sciences Inc. premium cannabis products which are then made available for sale to 1000's of future recreational cannabis customers in addition to current cannabis sales to existing medical-use dispensaries in Arizona.

The number of benefits CBD has is tremendous! These benefits include help with behavioral/neurological complications such as ADD/ADHD, anxiety, bipolar, OCD, PTSD, epilepsy, Parkinson's, osteoporosis, and ALS. CBD can also benefit pain management that can stem from headaches/migraines, arthritis, cramps, spinal injuries, and fibromyalgia. CBD has been found to also have gastrointestinal benefits with gastro-disorders and complications such as anorexia, cachexia, Crohn's, diabetes, and nausea. Physical complications/disorders such as muscular dystrophy and even immune system-based deficiencies and other complications such as cancer and hypertension even our bodies way and ability to maintain homeostasis have all been said to benefit from CBD.

LBC Bioscience Inc. is well stocked already as it is with some very high-quality CBD offerings - all at very reasonable prices. Check out LBC Bioscience Inc's newest product offerings including its: 100MG CBD Bath Bombs in a variety of scents, Delta 8 Gummies, 1500 MG Premium Berry Drops, and a variety of all-new Skincare products. Or shop our top selling products (based on order frequency) which include our CBD Pain Cream, CBD Oils and CBD Pet Treats.

CBD Life Sciences Inc. (CBDL) Stock Research Links

CBDL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 75

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Trimble's Q3 2026: Guidance Update and Record ARR

Updated Category News Views 48

Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....

Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Updated Category News Views 93

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 86

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 56

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026

Updated Category News Views 69

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Continue Reading
Allego Dominates 2026 Gartner Magic Quadrant: Why It Matters

Updated Category News Views 40

Allego Secures Top Spot Yet Again I've seen companies rise and fall on the whims of industry recognition, and let me tell ya, Allego's riding high on the right wave. For the second year running, this outfit's been named a Leader in the 2026 Gartner Magic Quadrant for Revenue Enablement Platforms. Recognized for its Completeness of Vision—yeah, that's no small feat...

Continue Reading
KOVE's Bold Lineup Expansion at EICMA 2026

Updated Category News Views 112

What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 6

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla's Earnings Impact: A Preview for Investors Ahead

Updated Category News Views 206

Tesla's Earnings and Market Dynamics As we gear up for Tesla's earnings announcement, all eyes are turning to the electric vehicle giant (NASDAQ: TSLA). Tesla is leading the charge as the first among the prominent group of tech companies known as the "Magnificent Seven" to reveal its financial performance. The anticipation builds as markets reflect on how business...

Continue Reading
Atos Group Releases Detailed Half-Year Financial Report for 2025

Updated Category News Views 222

Atos Group Updates on Financial Performance for 2025 Availability of the 2025 Half-year Financial Report Atos Group has made significant strides in its financial reporting for 2025, announcing the release of its half-year financial report. This document was published on the Atos website and was also filed with the French Financial Markets Authority (AMF). Insights from...

Continue Reading
Anywhere Real Estate and Canva Team Up for Agents' Success

Updated Category News Views 204

Anywhere Real Estate's Exciting New Partnership Anywhere Real Estate Inc. (NYSE: HOUS), a global frontrunner in the residential real estate sector, has recently unveiled an impactful collaboration with Canva, a recognized visual communication platform. This agreement aims to empower Every agent within their extensive network. Enhanced Tools for Affiliated Agents This...

Continue Reading
THEON Showcases Innovative A.R.M.E.D. Ecosystem at IDEX 2025

Updated Category News Views 279

THEON Unveils Revolutionary A.R.M.E.D. Ecosystem At IDEX 2025, THEON made a significant impact by showcasing its A.R.M.E.D. (Augmented Reality Modular Ecosystem of Devices), designed to elevate the capabilities of tomorrow's soldiers. This integrated solution promises to improve tactical awareness, effectiveness, and survivability for modern combat operatives....

Continue Reading
Exploring Advances in Arthrogryposis at Montreal Symposium

Updated Category News Views 304

4th International Symposium on Arthrogryposis Unveiled in Montreal MONTREAL — The Shriners Hospitals for Children - Canada is set to host the much-anticipated 4th International Symposium on Arthrogryposis from September 28 to October 1. This initiative brings together renowned healthcare professionals and researchers from various pediatric centers in Montreal,...

Continue Reading